Effects of 3-Hydroxypyridine and Succinic Acid Derivatives on Monoamine Oxidase Activity In Vitro


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Тек жазылушылар үшін

Аннотация

The effects of original Russian 3-hydroxypyridine and succinic acid derivatives (emoxypine, Reamberin, and Mexidol) on monoamine oxidase (MAO-A and MAO-B) activity in rat liver were studied in vitro. The study drugs used in vitro at concentrations in the pharmacokinetic range (10 9 to 10 6 M), were found to have MAO-modulating actions, the directions depending on their chemical structural properties. The isolated 3-hydroxypyridine derivative emoxypine decreased MAO-A activity by 34 – 44% and MAO-B activity by 9 – 10% (p < 0.05 in both cases). The succinic acid derivative Reamberin increased MAO-A activity by 2-3% and MAO-B activity by 14% (p < 0.05 in both cases). Mexidol, which is a derivative of both 3-hydroxypyridine and succinic acid, decreased MAO-A activity by 13% and MAO-B activity by 4% (p < 0.05 in both cases). The 2-ethyl-3-methyl-3-hydroxypyridinium cation and the succinate anion were antagonists in terms of their MAO-modulating actions. Combining these antagonist ions into the structure of Mexidol led to complete loss of the MAO-stimulating effect of the succinate part and a significant reduction in the MAO-inhibiting action of the 3-hydroxypyridine component.

Авторлар туралы

I. Volchegorskii

Southern Urals State Medical University, Ministry of Health of the Russian Federation

Хат алмасуға жауапты Автор.
Email: volcheg@yandex.ru
Ресей, 64 Vorovskii Street, Chelyabinsk, 454092

A. Sinitskii

Southern Urals State Medical University, Ministry of Health of the Russian Federation

Email: volcheg@yandex.ru
Ресей, 64 Vorovskii Street, Chelyabinsk, 454092

I. Miroshnichenko

Southern Urals State Medical University, Ministry of Health of the Russian Federation

Email: volcheg@yandex.ru
Ресей, 64 Vorovskii Street, Chelyabinsk, 454092

L. Rassokhina

Southern Urals State Medical University, Ministry of Health of the Russian Federation

Email: volcheg@yandex.ru
Ресей, 64 Vorovskii Street, Chelyabinsk, 454092


© Springer Science+Business Media, LLC, part of Springer Nature, 2018

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>